These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16652380)

  • 61. Do women have realistic expectations of treatment for stress urinary incontinence?
    Langford CF; Elmissiry MM; Ghoniem GM
    Neurourol Urodyn; 2008; 27(6):480-4. PubMed ID: 18551570
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adherence to a behavioral program to prevent incontinence.
    Hines SH; Seng JS; Messer KL; Raghunathan TE; Diokno AC; Sampselle CM
    West J Nurs Res; 2007 Feb; 29(1):36-56; discussion 57-64. PubMed ID: 17228060
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcomes in urinary incontinence: reconciling clinical relevance with scientific rigour.
    Tannenbaum C; Corcos J
    Eur Urol; 2008 Jun; 53(6):1151-61. PubMed ID: 18328618
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Does sexual function change after surgery for stress urinary incontinence and/or pelvic organ prolapse? A multicenter prospective study.
    Rogers RG; Kammerer-Doak D; Darrow A; Murray K; Qualls C; Olsen A; Barber M
    Am J Obstet Gynecol; 2006 Nov; 195(5):e1-4. PubMed ID: 17074540
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Performance-based or self-report measures of physical function: which should be used in clinical trials of hip fracture patients?
    Latham NK; Mehta V; Nguyen AM; Jette AM; Olarsch S; Papanicolaou D; Chandler J
    Arch Phys Med Rehabil; 2008 Nov; 89(11):2146-55. PubMed ID: 18996244
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Posterior tibial nerve stimulation in the treatment of urge incontinence.
    Vandoninck V; Van Balken MR; Finazzi Agró E; Petta F; Caltagirone C; Heesakkers JP; Kiemeney LA; Debruyne FM; Bemelmans BL
    Neurourol Urodyn; 2003; 22(1):17-23. PubMed ID: 12478596
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction.
    Foster RT; Anoia EJ; Webster GD; Amundsen CL
    Neurourol Urodyn; 2007; 26(2):213-7. PubMed ID: 17009252
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Urinary incontinence: common problem among women over 45.
    Swanson JG; Kaczorowski J; Skelly J; Finkelstein M
    Can Fam Physician; 2005 Jan; 51(1):84-5. PubMed ID: 16926957
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IQOL: translation & reliability for use with urinary incontinence patients in Thailand.
    Chaisaeng S; Santingamkun A; Opanuraks J; Ratchanon S; Bunyaratavej C
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S33-9. PubMed ID: 17722303
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Minimum 24-month followup of the sling for the treatment of stress urinary incontinence.
    Nazemi TM; Yamada B; Govier FE; Kuznetsov DD; Kodama K; Kobashi KC
    J Urol; 2008 Feb; 179(2):596-9. PubMed ID: 18082220
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness of functional magnetic versus electrical stimulation in women with urinary incontinence.
    Bölükbaş N; Vural M; Karan A; Yalçin O; Eskiyurt N
    Eura Medicophys; 2005 Dec; 41(4):297-301. PubMed ID: 16474284
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of fesoterodine on quality of life: pooled data from two randomized trials.
    Kelleher CJ; Tubaro A; Wang JT; Kopp Z
    BJU Int; 2008 Jul; 102(1):56-61. PubMed ID: 18564231
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
    Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Behavioral treatment of urinary incontinence: a complementary approach.
    Foster P
    Ostomy Wound Manage; 1998 Jun; 44(6):62-6, 68, 70. PubMed ID: 9739279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial.
    Burgio KL; Locher JL; Goode PS; Hardin JM; McDowell BJ; Dombrowski M; Candib D
    JAMA; 1998 Dec; 280(23):1995-2000. PubMed ID: 9863850
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Evaluation of the Global Abdominal Method (ABDO-MG) in the treatment of urinary incontinence].
    Godbout M; Le Tu M; Watier A; Black R
    Prog Urol; 2005 Sep; 15(4):756-61. PubMed ID: 16459704
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effectiveness of a new standardised Urinary Continence Physiotherapy Programme for community-dwelling older women in Hong Kong.
    Leong BS; Mok NW
    Hong Kong Med J; 2015 Feb; 21(1):30-7. PubMed ID: 25377297
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relationship between health promotion lifestyle profiles and patient outcomes of biofeedback therapy for urinary incontinence.
    Shinopulos NM; Jacobson J
    Urol Nurs; 1999 Dec; 19(4):249-53. PubMed ID: 10889768
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Office assessment of patient outcome of pharmacologic therapy for urge incontinence.
    Diokno AC; Catipay JR; Steinert BW
    Int Urogynecol J Pelvic Floor Dysfunct; 2002; 13(5):334-8. PubMed ID: 12355297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.